Security Snapshot

Journey Medical Corp - Common Stock (DERM) Institutional Ownership

CUSIP: 48115J109

13F Institutional Holders and Ownership History from Q4 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

76

Shares (Excl. Options)

11,022,797

Price

$7.71

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
DERM on Nasdaq
Shares outstanding
21,352,124
Price per share
$5.17
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
11,022,797
Total reported value
$84,985,269
% of total 13F portfolios
0%
Share change
+2,437,780
Value change
+$18,818,454
Number of holders
76
Price from insider filings
$5.17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • DERM - Journey Medical Corp - Common Stock is tracked under CUSIP 48115J109.
  • 76 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 76 to 7 between Q4 2025 and Q1 2026.
  • Reported value moved from $84,985,269 to $10,205,171.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 76 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 48115J109?
CUSIP 48115J109 identifies DERM - Journey Medical Corp - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Journey Medical Corp - Common Stock (DERM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WASATCH ADVISORS LP 10% +47% $16,554,951 +$7,614,973 2,133,370 +85% Wasatch Advisors LP 31 Mar 2026
TANG CAPITAL MANAGEMENT LLC 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 5.6% $5,657,993 1,206,395 Vanguard Capital Management 31 Mar 2026

As of 31 Dec 2025, 76 institutional investors reported holding 11,022,797 shares of Journey Medical Corp - Common Stock (DERM). This represents 52% of the company’s total 21,352,124 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Journey Medical Corp - Common Stock (DERM) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
TANG CAPITAL MANAGEMENT LLC 8.7% 1,854,596 0% 0.71% $14,298,935
WASATCH ADVISORS LP 6.2% 1,316,275 +0.77% 0.06% $10,148,480
Opaleye Management Inc. 4.6% 975,000 +0.41% 1% $7,517,250
J. Goldman & Co LP 3.7% 798,366 0.24% $6,155,402
VANGUARD GROUP INC 3.6% 764,147 +24% 0% $5,891,574
BlackRock, Inc. 3.4% 719,784 +14% 0% $5,549,535
MILLENNIUM MANAGEMENT LLC 2.1% 457,812 0% $3,529,731
Pale Fire Capital SE 2.1% 444,642 +95% 0.44% $3,428,190
Summit Financial, LLC 1.8% 390,419 +2.8% 0.04% $3,010,130
ESSEX INVESTMENT MANAGEMENT CO LLC 1.6% 345,977 -2.3% 0.41% $2,667,483
GEODE CAPITAL MANAGEMENT, LLC 1.5% 313,970 +13% 0% $2,420,885
UBS Group AG 1.4% 290,226 +100% 0% $2,237,642
Ikarian Capital, LLC 1.2% 251,436 0.25% $1,938,572
RENAISSANCE TECHNOLOGIES LLC 1.1% 244,000 -1.6% 0% $1,881,240
AMERICAN FINANCIAL GROUP INC 0.84% 180,000 0% 0.5% $1,387,800
STATE STREET CORP 0.81% 173,337 +19% 0% $1,336,428
Legato Capital Management LLC 0.52% 111,695 +9.6% 0.07% $861,168
SEI INVESTMENTS CO 0.51% 109,351 0% $843,096
NORTHERN TRUST CORP 0.44% 93,669 +1% 0% $722,188
Informed Momentum Co LLC 0.42% 89,389 0% 0.08% $689,189
CITADEL ADVISORS LLC 0.33% 69,415 +382% 0% $535,189
BOOTHBAY FUND MANAGEMENT, LLC 0.32% 67,442 0.01% $519,978
Geneos Wealth Management Inc. 0.3% 63,280 0% 0.01% $487,889
LAZARD ASSET MANAGEMENT LLC 0.29% 62,525 0% $482,068
Diametric Capital, LP 0.24% 51,683 0.11% $398,475

Institutional Holders of Journey Medical Corp - Common Stock (DERM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,175,943 $10,205,171 +$3,655,987 $4.69 7
2025 Q4 11,022,797 $84,985,269 +$18,818,454 $7.71 76
2025 Q3 8,692,790 $61,930,042 +$15,659,236 $7.12 67
2025 Q2 6,494,302 $46,629,314 +$11,145,137 $7.18 56
2025 Q1 5,017,760 $29,603,817 +$7,390,927 $5.90 38
2024 Q4 3,813,405 $14,909,751 +$6,149,987 $3.91 38
2024 Q3 2,156,982 $12,186,357 -$1,194,242 $5.65 36
2024 Q2 2,360,259 $13,310,203 +$3,384,583 $5.64 35
2024 Q1 1,816,385 $6,678,973 +$973,921 $3.68 31
2023 Q4 1,341,390 $7,982,763 -$492,957 $5.76 34
2023 Q3 2,135,266 $5,850,655 +$1,401,524 $2.74 20
2023 Q2 1,652,825 $2,627,537 -$24,753 $1.59 19
2023 Q1 1,668,350 $2,620,320 -$179,207 $1.57 16
2022 Q4 2,672,478 $5,131,893 -$313,986 $1.92 18
2022 Q3 1,878,524 $4,621,000 +$328,580 $2.46 18
2022 Q2 1,759,431 $6,580,100 +$289,703 $3.74 12
2022 Q1 1,644,289 $7,940,000 +$35,914 $4.83 13
2021 Q4 1,627,492 $8,756,000 +$8,756,000 $5.38 14
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .